Growth Opportunities and Trends in the Vitamin D Therapy Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the vitamin d therapy market grown over the years?
The market size for vitamin D therapy has seen a quick advancement in recent times. It’s projected to escalate from $2.92 billion in 2024 to $3.27 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.1%. The noteworthy growth observed in the historical period is largely due to the heightened awareness around vitamin D deficiencies, increasing number of bone disorder cases, an aging populace and frequency of osteoporosis, research shedding light on the benefits, the rise in lifestyle-centric ailments, and medical guidelines promoting supplementation.
What Is the forecasted market size and growth rate for the vitamin d therapy market?
The market size for vitamin D therapy is anticipated to experience steep expansion in the following years, forecasted to reach $5.44 billion by 2029 at an impressive compound annual growth rate (CAGR) of 13.6%. This predicted upswing in the coming period is mainly attributed to increasing awareness and education, a swelling elderly population, incorporation of vitamin D in the management of chronic conditions, advances in formulation technologies, worldwide health drives, and heightened attention to individualized nutrition. The forecast period is also likely to observe key trends such as the broadening usage scope beyond bone health, government undertaken supplementation initiatives, innovative formulation and delivery methods, emphasis on clinical studies and evidence-based approaches, in addition to expansion of the global market.
Get your vitamin d therapy market report here!
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report
What are the major factors driving growth in the vitamin d therapy market?
The escalation in the number of malnutrition instances is anticipated to fuel the expansion of the vitamin D therapy market in the future. Malnutrition denotes deficiency or over-consumption, imbalance of essential nutrients, or hindered nutrient absorption. Vitamin D deficiency is rampant among malnourished patients and is inversely linked to long-term survival, particularly in patients without vitamin D treatment. Consequently, the escalating number of malnutrition cases raises the demand for vitamin D therapy. For instance, as per the World Health Organization, a health promotion agency based in Switzerland that aims at ensuring world safety and serving the vulnerable, in March 2024, it was estimated that in 2022, around 390 million adults aged above 18 years globally were underweight, while a staggering 2.5 billion were overweight, including 890 million suffering from obesity. Among the age group of 5-19 years, 390 million were overweight, inclusive of 160 million with obesity. Additionally, 190 million were grappling with thinness. Approximately 149 million children younger than 5 years were experiencing stunted growth, while 37 million were overweight or obese. Almost half of the deaths among children younger than 5 years are attributed to undernutrition. Hence, the growing incidence of malnutrition cases is propelling the growth of the vitamin D therapy market.
What key areas define the segmentation of the global vitamin d therapy Market?
The vitamin d therapy market covered in this report is segmented –
1) By Administration: Oral, Parenteral
2) By Purchasing: OTC Drugs, Prescription Drugs
3) By Age Group: Children, Adults, Senior Adults
4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders
Subsegments:
1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages
2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp
What are the top market players propelling the growth of the vitamin d therapy industry?
Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.
What are the key trends shaping the future of the vitamin d therapy market?
In the vitamin D therapy market, product innovations are emerging as a significant trend. Key players in the market are leveraging these innovations to maintain their market dominance. For instance, Cadila Pharmaceuticals Pvt Ltd., a multi-national Indian pharmaceutical company, set a new industry standard in February 2024 by launching its Aqueous Cholecalciferol Injection – the first of its kind. This innovative product offers a speedy resolution for Vitamin D deficiency. Furthermore, its superior pharmacokinetics (PK) and pharmacodynamics (PD) outstrips traditional oil-based cholecalciferol preparations available in the market, showcasing the power of this breakthrough innovation.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8810
What regions are dominating the vitamin d therapy market growth?
North America was the largest region in the vitamin D therapy market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin D therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Nutritional Feed Additives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report
Food Encapsulation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-encapsulation-global-market-report
Functional Foods Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/functional-foods-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: